|
Key: Meeting 
Journal 
Funder 
Showing releases 1-25 out of 2932. 1 | 2 | 3 | 4 | 5 > >>
Public Release: 23-May-2012
Environmental Health Perspectives
Socioeconomics may affect toddlers' exposure to flame retardants
A Duke University-led study of North Carolina toddlers suggests that exposure to potentially toxic flame-retardant chemicals may be higher in nonwhite toddlers than in white toddlers.
NIH/National Institute of Environmental Health Sciences
Contact: Tim Lucas
tdlucas@duke.edu
919-613-8084
Duke University
Public Release: 23-May-2012
Radiology
Breast MRI helps predict chemotherapy's effectiveness
MRI provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study.
NIH/National Cancer Institute
Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Public Release: 22-May-2012
Proceedings of the National Academy of Sciences
Scientists unravel role of fusion gene in prostate cancer
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein -- but no one has known how that alteration promotes cancer growth.
US Department of Defense, National Science Foundation, NIH/National Cancer Institute, Starr Cancer Consortium
Contact: Lauren Woods
law2014@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Public Release: 22-May-2012
PLoS ONE
Newly discovered breast milk antibodies help neutralize HIV
Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.
National Institutes of Health, Doris Duke Foundation Clinical Scientist Development Award, Gates Foundation, others
Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Public Release: 22-May-2012
UC San Diego Superfund Research Program receives $15 million grant renewal
The National Institute of Environmental Health Sciences, part of the National Institutes of Health, has renewed funding for the Superfund Research Program at the University of California, San Diego. Over the next five years, the $15 million grant will fund continued research on the molecular and genetic consequences of exposure to uncontrolled toxicants from Superfund and other hazardous waste sites.
NIH/National Institute of Environmental Health Sciences
Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Public Release: 22-May-2012
Journal of Biological Chemistry
Neuron-nourishing cells appear to retaliate in Alzheimer's
When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report.
National Institutes of Health
Contact: Toni Baker
tbaker@georgiahealth.edu
706-721-4421
Georgia Health Sciences University
Public Release: 22-May-2012
American Thoracic Society International Conference
New England Journal of Medicine
Intensivists at night improve patient outcomes in some ICUs, says Pitt/UPMC team
Intensive care units that had no or limited access to critical care doctors during the day can improve patient outcomes by having the specialists, called intensivists, man the unit at night, according to a study led by researchers at the University of Pittsburgh School of Medicine and UPMC. However, the researchers were unable to find any incremental benefit of nighttime staffing in ICUs that were robustly staffed with the specialists during the day.
NIH/National Heart, Lung and Blood Institute
Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-720-2058
University of Pittsburgh Schools of the Health Sciences
Public Release: 22-May-2012
mBio
Harvard team cracks code for new drug resistant superbugs
National Institutes of Health-funded scientists have determined the genetic sequences of all 12 available strains of Staphylococcus aureus bacteria resistant to vancomycin -- an antibiotic of last resort -- and have demonstrated that resistance arose independently in each strain after it acquired a specific bit of genetic material called transposon Tn1546.
National Institutes of Health
Contact: Mary Leach
Mary_Leach@meei.harvard.edu
617-573-4170
Massachusetts Eye and Ear Infirmary
Public Release: 21-May-2012
Cell Reports
Study reveals how high-fat foods impact diabetes and metabolic syndrome
University of Michigan Health System study shows Bcl10 protein helps the free fatty acids found in high-fat foods impair insulin action and raise blood sugar.
National Institutes of Health, Michigan Diabetes Research and Training Center
Contact: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System
Public Release: 21-May-2012
Proceedings of the National Academy of Sciences
University of Hawaii Cancer Center researchers create new anti-cancer drug
A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers.
The development of BP-1-102 was guided by the research teams computer based molecular analysis of the cancer causing Stat 3 protein.
NIH/National Cancer Institute
Contact: Bryan Cheplic
bcheplic@cc.hawaii.edu
808-564-5911
University of Hawaii Cancer Center
Public Release: 21-May-2012
Nature Neuroscience
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue of Nature Neuroscience.
National Institutes of Health, National Science Foundation, Basil O'Connor Starter Scholar Award, Klingenstein Fund, National Alliance for Research in Schizophrenia and Affective Disorders
Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Public Release: 21-May-2012
PLoS Pathogens
Type of viral infection of eye associated with disease causing blindness in the elderly
A team of researchers, including a scientist from the Viral Immunology Center at Georgia State University, have found that a type of herpesvirus infection of the eye is associated with neovascular age-related macular degeneration, a disease that causes blindness in the elderly.
National institutes of Health
Contact: Jeremy Craig
jcraig@gsu.edu
404-413-1357
Georgia State University
Public Release: 21-May-2012
Journal of Biological Chemistry
Strategy discovered to activate genes that suppress tumors and inhibit cancer
A promising new strategy for "reactivating" genes that cause cancer tumors to shrink and die has been developed by a research team led by two Penn State University scientists. The discovery may aid the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs.
NIH/National Cancer Institute, Penn State Clinical and Translational Science Institute
Contact: Barbara Kennedy
science@psu.edu
814-863-4682
Penn State
Public Release: 21-May-2012
American Journal of Cardiology
Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis
Heart disease risk assessment tools commonly used by physicians often underestimate the cardiovascular disease danger faced by rheumatoid arthritis patients, a Mayo Clinic study has found.
Pfizer Inc., NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Contact: Sharon Theimer
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Public Release: 21-May-2012
Journal of the American Medical Informatics Association
To dictate or not to dictate?
Could the quality of care you receive be affected by how your doctor takes notes? According to a new study by researchers at Brigham and Women's Hospital, doctors who dictated their patient notes appeared to have worse quality of care than
those who used structured documentation.
NIH/National Heart, Lung and Blood Institute
Contact: Marjorie Montemayor-Quellenberg
mmontemayor-quellenberg@partners.org
617-534-2208
Brigham and Women's Hospital
Public Release: 21-May-2012
Proceedings of the National Academy of Sciences
Study: Heart damage after chemo linked to stress in cardiac cells
Blocking a protein in the heart that is produced under stressful conditions could be a strategy to prevent cardiac damage that results from chemotherapy, a new study suggests.
National Institutes of Health
Contact: Govindasamy Ilangovan
Govindasamy.ilangovan@osumc.edu
614-292-9064
Ohio State University
Public Release: 21-May-2012
Genome Biology
Breast-fed babies' gut microbes contribute to healthy immune systems
A new multi-university study reports that differences in bacterial colonization of the infant gut in formula-fed and breast-fed babies lead to changes in the expression of genes involved in the infant's immune system.
National Institutes of Health, US Department of Agriculture
Contact: Phyllis Picklesimer
p-pickle@illinois.edu
217-244-2827
University of Illinois College of Agricultural, Consumer and Environmental Sciences
Public Release: 21-May-2012
Proceedings of the National Academy of Sciences
Surgical removal of abdominal fat reduces skin cancer in mice
In animal studies, Rutgers scientists have found that surgical removal of abdominal fat from mice fed a high-fat diet reduces the risk of ultraviolet-light induced skin cancer – the most prevalent cancer in the United States with more than two million new cases each year – by up to 80 percent.
NIH/National Cancer Institute, NIH/National Institute of Environmental Health Sciences
Contact: Robin Lally
rlally@ur.rutgers.edu
732-932-7084 x652
Rutgers University
Public Release: 21-May-2012
Cancer Cell
Discovery suggests new combination therapy strategy for basal-like breast cancers
A new study led by UNC Lineberger scientist Charles Perou, Ph.D., and Sean Egan, Ph.D., from the Hospital for Sick Children in Toronto, Ontario, demonstrates that deletion of a sugar transferase called LFNG, promotes cell proliferation and tumor formation of basal-like breast cancers.
Canadian Cancer Society Research Institute, Susan G. Komen for the Cure, Genome Canada, NIH/National Cancer Institute Breast SPORE Program, Breast Cancer Research Foundation
Contact: Ellen de Graffenreid
edegraff@med.unc.edu
919-962-3405
University of North Carolina Health Care
Public Release: 21-May-2012
Proceedings of the National Academy of Sciences
Touching tarantulas
A brief therapy session for adults with a lifelong debilitating spider phobia resulted in lasting changes to the brain's response to fear. The therapy was so successful, the adults were able to hold a tarantula in their bare hands six months after the treatment. This is the first study to document the immediate and long-term brain changes after treatment and to illustrate how the brain reorganizes long-term to reduce fear.
NIH/National Institute of Neurological Disorders and Stroke, Northwestern University, Association for Behavioral and Cognitive Therapies
Contact: Marla Paul
Marla-Paul@northwestern.edu
312-503-8928
Northwestern University
Public Release: 21-May-2012
Proceedings of the National Academy of Sciences
Diabetes drug target identified
New research from the University of Cincinnati points to the naturally produced protein apolipoprotein A-IV as a potential target for a new diabetes therapeutic.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Contact: Dama Ewbank
dama.ewbank@uc.edu
513-558-4519
University of Cincinnati Academic Health Center
Public Release: 21-May-2012
Digestive Disease Week
Mayo Clinic: Pancreatic cancer may be detected with simple intestinal probe
By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study.
National Institutes of Health, Mayo Clinic
Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Public Release: 21-May-2012
Journal of Clinical Oncology
Study finds moderate weight loss reduces levels of sex hormones linked to breast cancer risk
Even a moderate amount of weight loss can significantly reduce levels of circulating estrogen that are associated with an increased risk of breast cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center -- the first randomized, controlled clinical trial to test the effects of weight loss on sex hormones in overweight and obese postmenopausal women, a group at elevated risk for breast cancer.
National Institutes of Health, NIH/National Cancer Institute, Canadian Institutes of Health Research
Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Public Release: 21-May-2012
Proceedings of the National Academy of Sciences
Physical properties predict stem cell outcome
Tissue engineers can use mesenchymal stem cells derived from fat to make cartilage, bone, or more fat. The best cells to use are ones that are already likely to become the desired tissue. Brown University researchers have discovered that the mechanical properties of the stem cells can foretell what they will become, leading to a potential method of concentrating them for use in healing.
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH/National Institute of General Medical Sciences
Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Public Release: 21-May-2012
Proceedings of the National Academy of Sciences
'Orphan' sleep drug may be potent cancer-fighting agent
An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more effective cancer therapies.
NIH/National Institute on Aging, Fred Hutchinson/University of Washington Cancer Consortium, Ben Towne Foundation
Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Showing releases 1-25 out of 2932. 1 | 2 | 3 | 4 | 5 > >>
|
RSS Feed
